• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

Vaccines

?
-

Resources for You

Gardasil

Proper Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant
Tradename: Gardasil
Manufacturer: Merck & Co., Inc, License #0002
Indications: 

  • Prevention of vulvar and vaginal cancer
  • Vaccination in females 9 through 26 years of age for prevention of the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18:
    • Cervical cancer
    • Genital warts (condyloma acuminata) and the following precancerous or dysplastic lesions:
      • Cervical adenocarcinoma in situ (AIS)
      • Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3
      • Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3
      • Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3
      • Cervical intraepithelial neoplasia (CIN) grade 1
  • Vaccination in boys and men 9 through 26 years of age for the prevention of genital warts caused by HPV types 6 and 11
  • Vaccination in people ages 9 through 26 years for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18
-

Supporting Documents

-
 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002